EQS Preliminary announcement financial reports: R. Stahl AG / Preliminary announcement on the disclosure of financial statements
R. Stahl AG: Preliminary announcement of the publication. | November 3, 2022
LifeMine Therapeutics Inc., a biopharmaceutical company reinventing drug discovery by mininggenetically-encoded small molecules (GEMs) from the biosphere, today announced the appointments of Martin Stahl
Stahl has confirmed a new distribution agreement with Univar Solutions, a leading global solutions provider to users of specialty ingredients and chemicals for coatings, adhesives, sealants, and elastomers.